Anti-CD105 Inhibits Primary Cancer Growth and Secondary Hematoge- nous Metastasis in a Xenograft Model
نویسندگان
چکیده
CD105, a receptor for TGF-b1 and -b-3 modulates TGF-b signaling by interacting with TGF-bRI and/or II. It is now emerging as a prime vascular target of antiangiogenetic cancer therapy. In the present study, we investigate the efficacy of CD105 in colorectal cancer models. We found decreases in tumor size and in the number of metastatic foci to lung in a xenograft cancer model in scid mouse that was treated with Anti-CD105 antibody. The necrotic area in the tumor was greater in the anti-CD105 antibody group than that of the control group. The number of metastatic foci and the area of metastasis were also lesser in the anti-CD105 group than those of the control group. A direct effect of anti-CD105 antibody to the cultured colon cancer cell line was not detected in respect to morphology and proliferation. Decreased vasculature by an antiangiogenic effect of anti-CD105 antibody was confirmed by an immunohistochemical assessment of CD105 expression on frozen tumor tissue. These findings demonstrated that CD105 was specifically expressed in vascular endothelial cells in a xenograft colon cancer model, and anti-CD-105 antibody inhibited both tumor growth and hematogenous metastasis by blocking the vascular network. CD105 is a useful target and anti-CD105 antibody is a candidate for antiangiogenic colorectal cancer therapy.
منابع مشابه
Long non-coding RNA FOXO1 inhibits lung cancer cell growth through down-regulating PI3K/AKT signaling pathway
Objective(s): Lung cancer is one of the most common malignant tumors, which seriously threatens the health and life of the people. Recently, a novel long non-coding RNA (lncRNA) termed lncFOXO1 was found and investigated in breast cancer. However, the effect of lncFOXO1 on lung cancer is still ambiguous. The current study aimed to uncover the functions of lncFOXO1 in l...
متن کاملInhibition of breast cancer growth and metastasis by a biomimetic peptide
Metastasis is the main cause of mortality in cancer patients. Though there are many anti-cancer drugs targeting primary tumor growth, anti-metastatic agents are rarely developed. Angiogenesis and lymphangiogenesis are crucial for cancer progression, particularly, lymphangiogenesis is pivotal for metastasis in breast cancer. Here we report that a novel collagen IV derived biomimetic peptide inhi...
متن کاملLithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cells
Metastasis is the main cause of mortality in cancer patients. Although there are many anti-cancer drugs targeting tumor growth, anti-metastatic agents are rarely developed. Angiogenesis and lymphangiogenesis are crucial for cancer progression; in particular, lymphangiogenesis is pivotal for metastasis in cancer. Here we report that lithium inhibits colon cancer metastasis by blocking lymphangio...
متن کاملTumorigenicity of Esophageal Cancer Stem Cells (ECSCs) in nude mouse xenograft model
Background and objectives: Modeling cancer in vivo is a very important tool to investigate cancer pathogenesis and molecular mechanisms involved in cancer progression. Laboratory mice are the most common animal used for rebuilding human cancer in vivo. Cancer stem cells (CSCs) are the main reason of failure in cancer therapy because of tumor relapse and metastasis. Isolation of cancer stem cell...
متن کاملEstablishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern
Squamous cell carcinoma of the cervix, highly prevalent in the developing world, is often metastatic and treatment resistant with no standard treatment protocol. Our laboratory pioneered the patient-derived orthotopic xenograft (PDOX) nude mouse model with the technique of surgical orthotopic implantation (SOI). Unlike subcutaneous transplant patient-derived xenograft (PDX) models, PDOX models ...
متن کامل